Dean Regier

Title: **Inventor Spotlight: Dean Regier**

Introduction

Dean Regier is a notable inventor based in Upton, Massachusetts, known for his contribution to the field of biologic production through innovative methods. With a focus on advancing cell line development processes, Regier's work aims to enhance the efficiency and effectiveness of biological research and applications.

Latest Patents

Dean Regier holds a patent titled "Methods of selecting biologic-producing cell lines by next generation sequencing." This innovative patent discloses an optimized multi-step cell line screening method that leverages next generation sequencing (NGS) and mass spectrometry (MS). The method is designed to reduce variants within biologic-producing cell lines, thus significantly improving the efficiency of the cell line development process.

Career Highlights

Regier is an integral part of AbbVie Inc., a global biopharmaceutical company dedicated to developing advanced therapeutic solutions. His work at AbbVie emphasizes the utilization of cutting-edge technologies to foster breakthroughs in drug discovery and development.

Collaborations

Throughout his career, Dean Regier has collaborated with esteemed coworkers, including Junjian Liu and Sheng Zhang. Together, they have contributed to advancements in the field of biologic research, working on innovative solutions that impact therapeutic outcomes.

Conclusion

Dean Regier's contributions to the field of biologics through his patented methods highlight the critical role of inventors in driving innovation. His efforts to streamline the cell line development process demonstrate the importance of integrating technology with biological research, reinforcing the transformative potential of modern scientific approaches.